VivoSim prices up to $4M public offering, closes initial $3M tranche

VivoSim Labs, INC.

Initial closing raised $3M at $1.14/share; 286,557 shares + 2,345,022 pre-funded warrants sold.
Common warrants issued at 150% coverage, exercise price $1.71, expire 5 years from issuance.
Second $1M tranche contingent on stock price >$1.43 and avg daily volume >$100K.
Net proceeds ~$2.5M for working capital, R&D, and general corporate purposes.
Joseph Gunnar & Co. placement agent with 7.5% cash fee and 131,579 placement agent warrants.

item 1.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.92

VivoSim Labs, INC. entered into Securities Purchase Agreement with certain accredited investors (effective 2026-03-31).

Action: entry
Agreement: equity purchase
Counterparty: certain accredited investors
Effective: 2026-03-31

Exact text from the filing

In connection with the Offering, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) on March 31, 2026, the form of which is filed as Exhibit 10.1, and which contains customary representations and warranties and agreements of each party thereto and customary indemnification rights and oblig

View on SEC.gov

Browse all material agreements →

VivoSim Labs, INC. filing history →

Source: SEC EDGAR

accession 0001193125-26-142106

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.